Amenorrhea Clinical Trial
Official title:
Bioenergetics of Exercise-Induced Menstrual Disturbances
Menstrual disturbances are frequently observed in physically active women and female athletes. Short term prospective studies have shown that diet and exercise interventions can lead to decreases in Luteinizing hormone (LH) pulsatility, however these studies are unable to capture further changes in menstrual status. One longer term prospective study over two menstrual cycles showed that weight loss elicited menstrual disturbances, but there were no quantifiable measurements of energy availability. Thus, the primary purpose of this study was to assess how varying levels of energy deficiency created through a combination of caloric restriction and exercise affect menstrual function in young, premenopausal, sedentary women.
Long term energy deficiency in women can lead to functional hypothalamic amenorrhea (FHA), which can cause many health detriments such as osteopenia, stress fractures, transient infertility, dyslipidemia, and impaired endothelial function. Though studies involving diet and exercise interventions have shown how energy deficiency can lead to menstrual disturbances prospectively, this study aims to extend those findings by measuring the magnitude of energy deficit that could lead to these disturbances. Hypotheses for this study are: 1) there would be a dose-response relation between the induction of menstrual disturbances (luteal phase defects, anovulation, and oligomenorrhea) and the magnitude of energy deficiency such that the intervention groups experiencing a greater energy deficit would incur a significantly greater incidence of menstrual cycle disturbances and 2) the intervention groups experiencing a greater energy deficit would incur a greater incidence of more severe menstrual cycle disturbances. The study included one baseline menstrual cycle and 3 intervention menstrual cycles. During the baseline period, participants were randomly assigned to an experimental group for intervention menstrual cycles 1, 2, and 3 of the study. The goal of the subject groupings was to test the impact of varying levels of an energy deficit created by the combination of caloric restriction and exercise on menstrual function. They were assigned to either a control group that did not exercise and consumed a number of calories estimated to maintain body weight, a control group that exercised but received extra food calories to remain in energy balance (EXCON), or one of four groups that exercised and were prescribed reduced energy intake to create varying levels of an energy deficit. Specifically, the four groups of energy deficit were 1) an increase of 15 percent kcal of exercise (15 percent deficit, ED1), 2) an increase of 30 percent kcal of exercise (30 percent deficit, ED2), 3) a decrease of 15 percent in dietary intake combined with an increase of 15 percent of exercise, (30 percent deficit 15/15, ED2), and 4) a decrease of 30 percent in dietary intake combined with an increase of 30 percent kcal of exercise (60 percent deficit, ED3). The number of participants for analysis was 34 participants in the following groups: EXCON (n = 8), ED1 (n = 6), ED2 (n = 12), and ED3 (n = 8). Baseline energy needs were assessed during the baseline cycle. Resting metabolic rate and nonexercise physical activity were added to determine a caloric need for the day. Caloric intake was supervised throughout the entire study, and meals were comprised of 55 percent carbohydrates, 30 percent fat, and 15 percent protein. Exercise training was also supervised, and maximal oxygen consumption (VO2 max) was calculated. Menstrual status was assessed through analysis of daily urinary metabolites of estrone-1-glucuronide (E1G), pregnanediol glucuronide (PdG), and midcycle LH. Underwater weighing and a digital scale were used to assess body composition, and fasting blood samples were collected to assess metabolic hormones. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01927432 -
Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
|
||
Completed |
NCT00196391 -
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
|
Phase 2 | |
Completed |
NCT00152282 -
A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
|
Phase 2 | |
Recruiting |
NCT00456274 -
Baselines in Reproductive Disorders
|
N/A | |
Terminated |
NCT00556400 -
Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones
|
Phase 1/Phase 2 | |
Completed |
NCT00429494 -
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
|
Phase 2 | |
Completed |
NCT04135729 -
Mental Health in Fitness Instructors
|
||
Recruiting |
NCT03916978 -
Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
|
Phase 2/Phase 3 | |
Completed |
NCT00243607 -
Hydrotherapy Against Menopausal Symptoms in Breast Cancer Survivors
|
N/A | |
Completed |
NCT00001275 -
Ovarian Follicle Function in Patients With Primary Ovarian Failure
|
N/A | |
Recruiting |
NCT06280807 -
Observation of Environment and Reproductive-Endocrine Effects
|
||
Not yet recruiting |
NCT02393482 -
Psychological Impact of Amenorrhea in Women With Endometriosis
|
Phase 4 | |
Completed |
NCT01206153 -
Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients
|
Phase 4 | |
Recruiting |
NCT04424576 -
Ovarian Morphology in Girls
|
||
Completed |
NCT02224976 -
Effect of Intense Training on Ovarian Function and Bone Turnover
|
N/A | |
Active, not recruiting |
NCT01785719 -
Evaluation of Ovarian Morphology and Function in Overweight Women During Weight Loss
|
N/A | |
Recruiting |
NCT00383656 -
Pulsatile GnRH in Anovulatory Infertility
|
Phase 2 | |
Terminated |
NCT00881608 -
Study to Evaluate Menses Induction in Women Administered Proellex
|
Phase 1 | |
Active, not recruiting |
NCT01103518 -
Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation
|
Phase 4 | |
Withdrawn |
NCT00827151 -
Bone Mass Accrual in Adolescent Athletes
|
Phase 3 |